Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with 'inverted' binding mode

被引:57
作者
Darras, Fouad H. [1 ]
Wehle, Sarah [2 ]
Huang, Guozheng [1 ,2 ]
Sotriffer, Christoph A. [2 ]
Decker, Michael [1 ,2 ]
机构
[1] Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany
[2] Univ Wurzburg, Inst Pharm & Lebensmittelchem, D-97074 Wurzburg, Germany
关键词
Alzheimer's disease; Cholinesterase inhibitors; Computational study; Heterocycles; Quinazolinones; NITROGEN-BRIDGEHEAD COMPOUNDS; EMPIRICAL SCORING FUNCTIONS; ACETYLCHOLINESTERASE INHIBITORS; CHOLINESTERASE-INHIBITORS; ALZHEIMERS-DISEASE; GENETIC ALGORITHM; IDENTIFICATION; ALKALOIDS; COGNITION; DOCKING;
D O I
10.1016/j.bmc.2014.06.045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Selective and nanomolar acetylcholinesterase inhibitors were obtained by connecting tri- and tetracyclic quinazolinones-previously described as moderately active and unselective cholinesterase (ChE) inhibitors-via a hydroxyl group in para position to an anilinic nitrogen with different amines linked via a three carbon atom spacer. These tri- and tetracyclic quinazolinones containing different alicyclic ring sizes and connected to tertiary amines were docked to a high-resolution hAChE crystal structure to investigate the preferred binding mode in relation to results obtained by experimental structure-activity relationships. While the 'classical orientation' locating the heterocycle in the active site was rarely found, an alternative binding mode with the basic aliphatic amine in the active center ('inverted' orientation) was obtained for most compounds. Analyses of extended SARs based on this inverted binding mode are able to explain the compounds' binding affinities at AChE. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4867 / 4881
页数:15
相关论文
共 50 条
[1]
New quinazolinone-pyrimidine hybrids: Synthesis, anti-inflammatory, and ulcerogenicity studies [J].
Abbas, Safinaz E. ;
Awadallah, Fadi M. ;
Ibrahin, Nashwa A. ;
Said, Eman G. ;
Kamel, Gihan M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 53 :141-149
[2]
Microscopic binding of butyrylcholinesterase with quinazolinimine derivatives and the structure-activity correlation [J].
AbdulHameed, Mohamed Diwan M. ;
Liu, Junjun ;
Pan, Yongmei ;
Fang, Lei ;
Silva-Rivera, Carlos ;
Zhan, Chang-Guo .
THEORETICAL CHEMISTRY ACCOUNTS, 2011, 130 (01) :69-82
[3]
Divergent Structure-Activity Relationships of Structurally Similar Acetylcholinesterase Inhibitors [J].
Andersson, C. David ;
Forsgren, Nina ;
Akfur, Christine ;
Allgardsson, Anders ;
Berg, Lotta ;
Engdahl, Cecilia ;
Qian, Weixing ;
Ekstrom, Fredrik ;
Linusson, Anna .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) :7615-7624
[4]
[Anonymous], PYMOL MOL GRAPH SYST
[5]
[Anonymous], GOLDSUITE 5 1 GOLDSU
[6]
Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.3.CO
[7]
2-N
[8]
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling [J].
Bembenek, Scott D. ;
Keith, John M. ;
Letavic, Michael A. ;
Apodaca, Richard ;
Barbier, Ann J. ;
Dvorak, Lisa ;
Aluisio, Leah ;
Miller, Kirsten L. ;
Lovenberg, Timothy W. ;
Carruthers, Nicholas I. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (06) :2968-2973
[9]
Berlin M, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P675, DOI 10.1016/B978-012369413-3/50088-4
[10]
A Medicinal Chemist's Guide to Molecular Interactions [J].
Bissantz, Caterina ;
Kuhn, Bernd ;
Stahl, Martin .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) :5061-5084